Praxis Precision Medicines Stock Price To Book
| PRAX Stock | USD 69.90 3.34 5.02% |
Praxis Precision Medicines fundamentals help investors to digest information that contributes to Praxis Precision's financial success or failures. It also enables traders to predict the movement of Praxis Stock. The fundamental analysis module provides a way to measure Praxis Precision's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Praxis Precision stock.
Price To Book Ratio is likely to drop to 1.62 in 2024. Praxis | Price To Book |
Praxis Precision Medicines Company Price To Book Analysis
Praxis Precision's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Current Praxis Precision Price To Book | 3.40 X |
Most of Praxis Precision's fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Praxis Precision Medicines is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Praxis Price To Book Driver Correlations
Understanding the fundamental principles of building solid financial models for Praxis Precision is extremely important. It helps to project a fair market value of Praxis Stock properly, considering its historical fundamentals such as Price To Book. Since Praxis Precision's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Praxis Precision's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Praxis Precision's interrelated accounts and indicators.
Click cells to compare fundamentals
Praxis Price To Book Historical Pattern
Today, most investors in Praxis Precision Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Praxis Precision's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's price to book growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Praxis Precision price to book as a starting point in their analysis.
Praxis Precision Price To Book |
| Timeline |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
| Competition |
Praxis Book Value Per Share
Book Value Per Share |
|
Based on the latest financial disclosure, Praxis Precision Medicines has a Price To Book of 3.4045 times. This is 86.74% lower than that of the Biotechnology sector and 43.63% lower than that of the Health Care industry. The price to book for all United States stocks is 64.2% higher than that of the company.
Praxis Price To Book Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Praxis Precision's direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Praxis Precision could also be used in its relative valuation, which is a method of valuing Praxis Precision by comparing valuation metrics of similar companies.Praxis Precision is currently under evaluation in price to book category among its peers.
Praxis Precision ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Praxis Precision's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Praxis Precision's managers, analysts, and investors.Environmental | Governance | Social |
Praxis Fundamentals
| Return On Equity | -0.64 | ||||
| Return On Asset | -0.39 | ||||
| Operating Margin | (188.20) % | ||||
| Current Valuation | 885.16 M | ||||
| Shares Outstanding | 18.64 M | ||||
| Shares Owned By Insiders | 0.24 % | ||||
| Shares Owned By Institutions | 99.76 % | ||||
| Number Of Shares Shorted | 1.53 M | ||||
| Price To Book | 3.40 X | ||||
| Price To Sales | 811.70 X | ||||
| Revenue | 2.45 M | ||||
| EBITDA | (125.94 M) | ||||
| Net Income | (123.28 M) | ||||
| Cash And Equivalents | 165.4 M | ||||
| Cash Per Share | 3.70 X | ||||
| Total Debt | 2.5 M | ||||
| Debt To Equity | 0.03 % | ||||
| Current Ratio | 4.56 X | ||||
| Book Value Per Share | 21.52 X | ||||
| Cash Flow From Operations | (111.14 M) | ||||
| Short Ratio | 3.97 X | ||||
| Earnings Per Share | (9.17) X | ||||
| Price To Earnings To Growth | 0.03 X | ||||
| Target Price | 146.5 | ||||
| Number Of Employees | 82 | ||||
| Beta | 2.69 | ||||
| Market Capitalization | 1.3 B | ||||
| Total Asset | 87.95 M | ||||
| Retained Earnings | (653.92 M) | ||||
| Working Capital | 69.13 M | ||||
| Net Asset | 87.95 M |
About Praxis Precision Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Praxis Precision Medicines's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Praxis Precision using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Praxis Precision Medicines based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Praxis Stock Analysis
When running Praxis Precision's price analysis, check to measure Praxis Precision's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Praxis Precision is operating at the current time. Most of Praxis Precision's value examination focuses on studying past and present price action to predict the probability of Praxis Precision's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Praxis Precision's price. Additionally, you may evaluate how the addition of Praxis Precision to your portfolios can decrease your overall portfolio volatility.